BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20570931)

  • 1. DNA ploidy cytometry testing for cervical cancer screening in China - letter.
    Garner DM; Guillaud MD; MacAulay CE
    Clin Cancer Res; 2010 Jul; 16(13):3517. PubMed ID: 20570931
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA ploidy cytometry testing for cervical cancer screening in China (DNACIC Trial): a prospective randomized, controlled trial.
    Tong H; Shen R; Wang Z; Kan Y; Wang Y; Li F; Wang F; Yang J; Guo X;
    Clin Cancer Res; 2009 Oct; 15(20):6438-45. PubMed ID: 19825960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA cytometry testing for cervical cancer screening: approaches and reporting standards for new technologies.
    Colditz GA; Crowley J
    Clin Cancer Res; 2011 Nov; 17(22):6971-2. PubMed ID: 21940755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy compared with human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation.
    Guillaud M; Benedet JL; Cantor SB; Staerkel G; Follen M; MacAulay C
    Cancer; 2006 Jul; 107(2):309-18. PubMed ID: 16773634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ploidy level and short-time prognosis of early cervix cancer.
    Jakobsen A
    Radiother Oncol; 1984 Jan; 1(3):271-5. PubMed ID: 6505263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The study of DNA ploidy as a prognostic factor in uterine cervical cancer].
    Watanabe Y; Ikeda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1127-34. PubMed ID: 1453042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy in adenocarcinoma in situ of the uterine cervix.
    Jaworski RC; Jones A
    J Clin Pathol; 1990 May; 43(5):435-6. PubMed ID: 2370314
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA ploidy and S-phase fraction as prognostic factors in cervical cancer.
    Rothenberg ML
    Cancer Treat Res; 1994; 70():53-62. PubMed ID: 8060751
    [No Abstract]   [Full Text] [Related]  

  • 11. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyribonucleic acid ploidy and S-phase fraction are not significant prognostic factors for patients with cervical cancer.
    Jelen I; Valente PT; Gautreaux L; Clark GM
    Am J Obstet Gynecol; 1994 Dec; 171(6):1511-6; discussion 1516-8. PubMed ID: 7802060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
    Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
    Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of image cytometry methodology for DNA ploidy analysis of cervical epithelium samples: a pilot study.
    Duarte CE; Carvalho CR; Silva-Filho AL
    Taiwan J Obstet Gynecol; 2014 Jun; 53(2):227-31. PubMed ID: 25017273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA distribution and chromosome number in human cervical carcinoma.
    Jakobsen A; Nielsen KV; Rønne M
    Anal Quant Cytol; 1983 Mar; 5(1):13-8. PubMed ID: 6846964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus testing for primary cervical cancer screening.
    Runowicz CD; Garozzo S
    Curr Oncol Rep; 2008 Nov; 10(6):533-7. PubMed ID: 18928670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials.
    Pileggi C; Flotta D; Bianco A; Nobile CG; Pavia M
    Int J Cancer; 2014 Jul; 135(1):166-77. PubMed ID: 24302411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA examinations in gynecological cancer and breast cancer].
    Tropé C; Kaern J; Pettersen EO; Iversen OE
    Tidsskr Nor Laegeforen; 1991 May; 111(13):1638-42. PubMed ID: 2063365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening trials in India spark controversy.
    Bagcchi S
    BMJ; 2014 May; 348():g3038. PubMed ID: 24789277
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive value of morphological nuclear parameters and DNA ploidy pattern in precancerous lesions of the uterine cervix.
    Kashyap V; Luthra UK
    Indian J Pathol Microbiol; 1995 Apr; 38(2):193-7. PubMed ID: 8919109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.